BioSyent Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	45.98	43.05	35.03	31.59	27.93	28.62
Revenue Growth (YoY)	20.13%	22.90%	10.89%	13.13%	-2.42%	28.15%
Cost of Revenue	11.19	10.09	7.17	5.99	5.07	5.98
Gross Profit	34.79	32.96	27.86	25.6	22.86	22.64
Selling, General & Admin	22.93	21.21	18.85	18.01	15.78	14.34
Research & Development	0.51	0.56	0.25	0.12	0.1	0.12
Total Operating Expenses	23.44	21.77	19.1	18.13	15.88	14.45
Operating Income	11.35	11.19	8.75	7.47	6.98	8.18
Interest Income	-0.87	-0.89	-1.09	-1.13	-0.53	-0.16
Interest Expense	0.07	0.05	0.06	0.07	0.08	0.09
Other Non-Operating Income (Expense)	-	-	-	-	-	0.13
Total Non-Operating Income (Expense)	-0.81	-0.84	-1.03	-1.06	-0.45	0.05
Pretax Income	12.16	12.03	9.78	8.53	7.43	8.38
Provision for Income Taxes	3.12	3.02	2.51	2.07	1.97	2.1
Net Income	9.04	9.01	7.27	6.46	5.46	6.28
Net Income to Common	9.04	9.01	7.27	6.46	5.46	6.28
Net Income Growth	15.54%	23.96%	12.54%	18.35%	-13.11%	65.51%
Shares Outstanding (Basic)	11	11	12	12	12	13
Shares Outstanding (Diluted)	12	12	12	12	13	13
Shares Change (YoY)	-1.57%	-2.55%	-2.98%	-2.95%	-2.57%	-1.70%
EPS (Basic)	0.79	0.80	0.63	0.54	0.44	0.49
EPS (Diluted)	0.78	0.78	0.62	0.53	0.43	0.49
EPS Growth	16.57%	27.11%	16.01%	22.07%	-10.86%	68.28%
Shares Outstanding	11.43	11.26	11.28	11.74	12.1	12.56
Free Cash Flow	12.39	8.96	8.62	5	4.9	4.59
Free Cash Flow Growth	38.33%	3.87%	72.58%	1.91%	6.79%	-33.29%
Free Cash Flow Per Share	1.07	0.78	0.73	0.41	0.39	0.36
Dividends Per Share	0.200	0.200	0.180	0.160	0.040	-
Dividend Growth	-	11.11%	12.50%	300.00%	-	-
Gross Margin	75.67%	76.57%	79.52%	81.03%	81.85%	79.10%
Operating Margin	24.69%	26.00%	24.99%	23.65%	25.00%	28.59%
Profit Margin	19.65%	20.93%	20.75%	20.45%	19.55%	21.95%
FCF Margin	26.94%	20.80%	24.61%	15.81%	17.55%	16.04%
EBITDA	12.48	12.05	9.34	7.93	7.43	8.64
EBITDA Margin	27.15%	27.98%	26.67%	25.09%	26.62%	30.19%
EBIT	11.35	11.19	8.75	7.47	6.98	8.18
EBIT Margin	24.69%	26.00%	24.99%	23.65%	25.00%	28.59%
Effective Tax Rate	25.68%	25.09%	25.68%	24.30%	26.54%	25.03%

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.